
Profitability, historical returns, and peer comparisons.
According to Holdco Nuvo Group D.G Ltd. Ordinary Shares’s latest financial reports and current stock price. The company's current ROE is -36.55%. This represents a change of 280.86% compared to the average of -9.60% of the last 4 quarters.
The mean historical ROE of Holdco Nuvo Group D.G Ltd. Ordinary Shares over the last ten years is -99.80%. The current -36.55% ROE has changed -63.38% with respect to the historical average. Over the past ten years (40 quarters), NUVO's ROE was at its highest in in the March 2023 quarter at 0.86%. The ROE was at its lowest in in the September 2023 quarter at -34.26%.
Average
-99.80%
Median
0.89%
Minimum
-1474.36%
Maximum
924.67%
Discovering the peaks and valleys of Holdco Nuvo Group D.G Ltd. Ordinary Shares ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 5.48%
Maximum Annual ROE = 924.67%
Minimum Annual Increase = -1150.92%
Minimum Annual ROE = -1474.36%
| Year | ROE | Change |
|---|---|---|
| 2023 | 49.87% | 5.48% |
| 2022 | 0.89% | -1150.92% |
| 2021 | -0.09% | -100.01% |
| 2020 | 924.67% | -162.72% |
The current ROE of Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
16.89%
5-year avg
-99.80%
10-year avg
-99.80%
Holdco Nuvo Group D.G Ltd. Ordinary Shares’s ROE is greater than Acarix AB (publ) (-100.09%), greater than Ainos, Inc. (-217.50%), greater than Bluejay Diagnostics, Inc. (-125.01%), less than CapForce Inc. (168.84%), less than DIH Holding US, Inc. (24.90%), less than Elutia Inc (940.81%), greater than ENvue Medical, Inc. (-60.47%), greater than Genenta Science S.p.A. (-36.82%), less than Neurobiological Technologies, Inc. (24.90%), greater than Osceola Gold, Inc. (-1.39%),
| Company | ROE | Market cap |
|---|---|---|
| -100.09% | $223.29M | |
| -217.50% | $4.72M | |
| -125.01% | $589.37K | |
| 168.84% | $86.75M | |
| 24.90% | $209.00 | |
| 940.81% | $37.22M | |
| -60.47% | $951.43K | |
| -36.82% | $14.91M | |
| 24.90% | $2.70K | |
| -1.39% | $26.93M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Holdco Nuvo Group D.G Ltd. Ordinary Shares using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Holdco Nuvo Group D.G Ltd. Ordinary Shares or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Holdco Nuvo Group D.G Ltd. Ordinary Shares's ROE?
How is the ROE calculated for Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO)?
What is the highest ROE for Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO)?
What is the 3-year average ROE for Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO)?
What is the 5-year average ROE for Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO)?
How does the current ROE for Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO) compare to its historical average?